Dufour, Jean-François

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: No | Yes

No

Agarwal, Kosh; Castells, Lluis; Mullhaupt, Beat; M.C. Rosenberg, William; McNabb, Brian; Arterburn, Sarah; Camus, Gregory; McNally, John; Brainard, Diana M.; Subramanian, G. Mani; Gonsalkorala, Enoka; Londoño, Maria; Dufour, Jean-François; Forns, Xavier (October 2017). Sofosbuvir/Velpatasvir for 12 Weeks in Genotype 1-4 HCV-Infected Liver Transplant Recipients (Unpublished). In: AASLD. Washington DC. October 2017.

Dufour, Jean-François (2017). Hepatology Highlights. Hepatology, 65(1), pp. 1-3. Wiley Interscience 10.1002/hep.28935

Dufour, Jean-François (2016). Time to Abandon NASH? Hepatology, 63(1), pp. 9-10. Wiley Interscience 10.1002/hep.28276

Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 61(4), pp. 1101-1103. Wiley Interscience 10.1002/hep.27749

Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 61(3), pp. 741-743. Wiley Interscience 10.1002/hep.27692

Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 61(1), pp. 1-3. Wiley Interscience 10.1002/hep.27602

Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 61(2), pp. 411-412. Wiley Interscience 10.1002/hep.27652

Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 60(6), pp. 1803-1805. Wiley Interscience 10.1002/hep.27557

Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 60(5), pp. 1455-1457. Wiley Interscience 10.1002/hep.27428

Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 60(4), pp. 1119-20. Wiley Interscience 10.1002/hep.27384

Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 60(3), pp. 773-775. Wiley Interscience 10.1002/hep.27327

Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 60(2), pp. 445-447. Wiley Interscience 10.1002/hep.27270

Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 60(1), pp. 1-3. Wiley Interscience 10.1002/hep.27226

Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 59(6), pp. 2059-2061. Wiley Interscience 10.1002/hep.27166

Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 59(5), pp. 1657-1659. Wiley Interscience 10.1002/hep.27130

Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 59(4), pp. 1217-1219. Wiley Interscience 10.1002/hep.27075

Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 59(3), pp. 743-745. Wiley Interscience 10.1002/hep.27021

Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 59(2), pp. 357-359. Wiley Interscience 10.1002/hep.26973

Dufour, Jean-François (2014). Hepatology highlights. Hepatology, 59(1), pp. 1-3. Wiley Interscience 10.1002/hep.26935

Beyoglu, Diren; Dufour, Jean-François; Idle, Jeffrey (February 2013). Lipid metabolomics in hepatocellular carcinoma (Unpublished). In: EASL Monothematic Conference. Luxembourg. Februar 2013.

Overbeck, K; Dufour, Jean-François; Müllhaupt, B; Helbling, B; Borovicka, J; Malinverni, R; Heim, M; Moradpur, D; Cerny, A; Rickenbach, M; Negro, F (2010). Impact of international consensus guidelines on atniviral therapy of chronic hepatitis C patients in Switzerland. Swiss medical weekly Muttenz: EMH Schweizerischer Ärzteverlag

Lepper, P M; Dufour, Jean-François (2009). [Elevated transaminases - what to do if everything was done?]. Praxis - schweizerische Rundschau für Medizin, 98(6), pp. 330-4. Bern: Huber

Keogh-Stroka, Deborah M.; Plock, Jan Alexander; Beldi, Guido; Frese, Steffen R.; Keogh, Adrian; Bisch-Knaden, Sonja Maria; Dufour, Jean-François; Brunner, Thomas; Candinas, Daniel (2006). Temporary hypoxic stress protects the liver from Fas-mediated apoptosis and ischemia reperfusion injury. In: 93. Jahreskongress der Schweizerischen Gesellschaft für Chirurgie. Lugano, Switzerland. 21.-23.6.2006.

Yes

Wandeler, Gilles; Mauron, Etienne; Atkinson, Andrew; Dufour, Jean-François; Kraus, David; Reiss, Peter; Peters, Lars; Dabis, François; Fehr, Jan; Bernasconi, Enos; van der Valk, Marc; Smit, Colette; Gjærde, Lars K; Rockstroh, Jürgen; Neau, Didier; Bonnet, Fabrice; Rauch, Andri (2019). Incidence of Hepatocellular Carcinoma in HIV/HBV-coinfected Patients on Tenofovir therapy: Relevance for Screening Strategies. (In Press). Journal of hepatology Elsevier 10.1016/j.jhep.2019.03.032

Lange, Franziska Naomi; Dufour, Jean-François (2019). Changing Epidemiology of HCC: How to Screen and Identify Patients at Risk? Digestive diseases and sciences, 64(4), pp. 903-909. Springer 10.1007/s10620-019-05515-8

Saigi-Morgui, Núria; Quteineh, Lina; Bochud, Pierre-Yves; Crettol, Severine; Kutalik, Zoltán; Mueller, Nicolas J; Binet, Isabelle; Van Delden, Christian; Steiger, Jürg; Mohacsi, Paul; Dufour, Jean-François; Soccal, Paola M; Pascual, Manuel; Eap, Chin B (2019). Genetic and clinic predictors of new onset diabetes mellitus after transplantation. The pharmacogenomics journal, 19(1), pp. 53-64. Nature Publishing Group 10.1038/s41397-017-0001-5

Cassano, Marco; Dufour, Jean-François (2019). Inflammation and microbiota fingerprint: Delphi's oracle for NAFLD-related HCC? Hepatology, 69(1), pp. 12-15. Wiley Interscience 10.1002/hep.30267

Quteineh, Lina; Wójtowicz, Agnieszka; Bochud, Pierre-Yves; Crettol, Severine; Vandenberghe, Frederik; Venetz, Jean-Pierre; Manuel, Oriol; Golshayan, Dela; Lehmann, Roger; Mueller, Nicolas J; Binet, Isabelle; van Delden, Christian; Steiger, Jürg; Mohacsi, Paul; Dufour, Jean-François; Soccal, Paola M; Kutalik, Zoltan; Marques-Vidal, Pedro; Vollenweider, Peter; Recher, Mike; ... (2019). Genetic immune and inflammatory markers associated with diabetes in solid organ transplant recipients. American journal of transplantation, 19(1), pp. 238-246. Wiley-Blackwell 10.1111/ajt.14971

Caversaccio, Nathalie I; Reina Caro, Maria Desiré; Prince Eladnani, Raja; Müller, Martin; Lewis, Clayton S; Bogdanov, Vladimir Y; Dufour, Jean-François; Angelillo, Anne (2018). Alternatively spliced tissue factor levels are elevated in the plasma of patients with chronic liver diseases. European journal of gastroenterology & hepatology, 30(12), pp. 1470-1475. Lippincott Williams & Wilkins 10.1097/MEG.0000000000001236

Beckebaum, Susanne; Herzer, Kerstin; Bauhofer, Artur; Gelson, William; De Simone, Paolo; de Man, Robert; Engelmann, Cornelius; Müllhaupt, Beat; Vionnet, Julien; Salizzoni, Mauro; Volpes, Riccardo; Ercolani, Giorgio; De Carlis, Luciano; Angeli, Paolo; Burra, Patrizia; Dufour, Jean-François; Rossi, Massimo; Cillo, Umberto; Neumann, Ulf; Fischer, Lutz; ... (2018). Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin Prophylaxis. Annals of transplantation, 23, pp. 789-801. International Scientific Information 10.12659/AOT.910176

Lim, Ho Yeong; Merle, Philippe; Weiss, Karl Heinz; Yau, Thomas; Ross, Paul; Mazzaferro, Vincenzo; Blanc, Jean-Frédéric; Ma, Yuk Ting; Yen, Chia Jui; Kocsis, Judit; Choo, Su Pin; Sukeepaisarnjaroen, Wattana; Gérolami, René; Dufour, Jean-François; Gane, Edward J; Ryoo, Baek-Yeol; Peck-Radosavljevic, Markus; Dao, Thong; Yeo, Winnie; Lamlertthon, Wisut; ... (2018). Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with -Mutated Hepatocellular Carcinoma. Clinical cancer research, 24(19), pp. 4650-4661. American Association for Cancer Research 10.1158/1078-0432.CCR-17-3588

Rajasekaran, Raviprasadh; Felser, Andrea; Nuoffer, Jean-Marc; Dufour, Jean-François; St-Pierre, Marie (2018). The histidine triad nucleotide-binding protein 2 (HINT-2) positively regulates hepatocellular energy metabolism. FASEB journal, 32(9), pp. 5143-5161. Federation of American Societies for Experimental Biology 10.1096/fj.201701429R

Agarwal, Kosh; Castells, Lluís; Müllhaupt, Beat; Rosenberg, William M C; McNabb, Brian; Arterburn, Sarah; Camus, Gregory; McNally, John; Stamm, Luisa M; Brainard, Diana M; Mani Subramanian, G; Mariño, Zoe; Dufour, Jean-François; Forns, Xavier (2018). Sofosbuvir/velpatasvir for 12 weeks in genotype 1-4 HCV-infected liver transplant recipients. Journal of hepatology, 69(3), pp. 603-607. Elsevier 10.1016/j.jhep.2018.05.039

Miethe, Sarah; Guarino, Maria; Alhamdan, Fahd; Simon, Hans-Uwe; Renz, Harald; Dufour, Jean-François; Potaczek, Daniel P; Garn, Holger (2018). Effects of obesity on asthma: immunometabolic links. Polish archives of internal medicine, 128(7-8), pp. 469-477. Medycyna Praktyczna, Kraków, Poland 10.20452/pamw.4304

Linecker, Michael; Frick, Lukas; Kron, Philipp; Limani, Perparim; Kambakamba, Patryk; Tschuor, Christoph; Langiewicz, Magda; Kachaylo, Ekaterina; Tian, Yinghua; Schneider, Marcel A; Ungethüm, Udo; Calo, Nicolas; Foti, Michelangelo; Dufour, Jean-François; Graf, Rolf; Humar, Bostjan; Clavien, Pierre-Alain (2018). Exercise Improves Outcomes of Surgery on Fatty Liver in Mice: A Novel Effect Mediated by the AMPK Pathway. (In Press). Annals of surgery Lippincott Williams & Wilkins 10.1097/SLA.0000000000002904

Margini, Cristina; Murgia, Giuseppe; Stirnimann, Guido; De Gottardi, Andrea; Semmo, Nasser; Casu, Stefania; Bosch, Jaime; Dufour, Jean-François; Berzigotti, Annalisa (2018). Prognostic Significance of Controlled Attenuation Parameter in Patients With Compensated Advanced Chronic Liver Disease. Hepatology communications, 2(8), pp. 929-940. Wiley 10.1002/hep4.1201

Puoti, Massimo; Foster, Graham R; Wang, Stanley; Mutimer, David; Gane, Edward; Moreno, Christophe; Chang, Ting Tsung; Lee, Samuel S; Marinho, Rui; Dufour, Jean-François; Pol, Stanislas; Hezode, Christophe; Gordon, Stuart C; Strasser, Simone I; Thuluvath, Paul J; Zhang, Zhenzhen; Lovell, Sandra; Pilot-Matias, Tami; Mensa, Federico J (2018). High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1-6 patients without cirrhosis. Journal of hepatology, 69(2), pp. 293-300. Elsevier 10.1016/j.jhep.2018.03.007

Gmür, Andrea; Kolly, Philippe; Knöpfli, Marina Janusheva; Dufour, Jean-François (2018). FACT-Hep increases the accuracy of survival prediction in HCC patients when added to ECOG Performance Status. Liver international, 38(8), pp. 1468-1474. Wiley 10.1111/liv.13711

Bill, Ruben; Montani, Matteo; Blum, Benedikt; Dufour, Jean-François; Escher, Robert; Bühlmann, Michael (2018). Favorable response to mammalian target of rapamycin inhibition in a young patient with unresectable fibrolamellar carcinoma of the liver. Hepatology, 68(1), pp. 384-386. Wiley Interscience 10.1002/hep.29853

Saran, Uttara; Guarino, Maria; Rodriguez Navarro, Sarai; Simillion, Cedric; Montani, Matteo; Foti, Michelangelo; Humar, Bostjan; St-Pierre, Marie; Dufour, Jean-François (2018). Anti-tumoral effects of exercise on hepatocellular carcinoma growth. Hepatology communications, 2(5), pp. 607-620. Wiley 10.1002/hep4.1159

Keiser, O; Giudici, F; Müllhaupt, B; Junker, C; Dufour, J-F; Moradpour, D; Bruggmann, P; Terziroli, B; Semela, D; Brezzi, M; Bertisch, B; Estill, J; Negro, F; Spoerri, A (2018). Trends in hepatitis C-related mortality in Switzerland. Journal of viral hepatitis, 25(2), pp. 152-160. Blackwell Science 10.1111/jvh.12803

Gerbes, Alexander; Zoulim, Fabien; Tilg, Herbert; Dufour, Jean-François; Bruix, Jordi; Paradis, Valérie; Salem, Riad; Peck-Radosavljevic, Markus; Galle, Peter R; Greten, Tim F; Nault, Jean-Charles; Avila, Matias A (2018). Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma. Gut, 67(2), pp. 380-388. BMJ Publishing Group 10.1136/gutjnl-2017-315068

Dufour, Jean-François (2017). In Memoriam: Professor Jürg Reichen (1946–2017). Journal of hepatology, 67(6), p. 1131. Elsevier 10.1016/j.jhep.2017.08.015

Kolly, Philippe; Knöpfli, Marina Janusheva; Dufour, Jean-François (2017). Effect of smoking on survival of patients with hepatocellular carcinoma. Liver international, 37(11), pp. 1682-1687. Wiley 10.1111/liv.13466

Kolly, Philippe; Waidmann, Oliver; Vermehren, Johannes; Moreno, Christophe; Vögeli, Isabelle; Berg, Thomas; Semela, David; Zeuzem, Stefan; Dufour, Jean-François (2017). Hepatocellular carcinoma recurrence after direct antiviral agent treatment: A European multicentre study. Journal of hepatology, 67(4), pp. 876-878. Elsevier 10.1016/j.jhep.2017.07.007

Gmür, Andrea; Kolly, Philippe; Knöpfli, Marina Janusheva; Dufour, Jean-François (October 2017). Quality of life assessment increases the accuracy survival prediction in HCC patient. Hepatology, 66(1), 715A-715A. Wiley Interscience

Puoti, M; Foster, G; Wang, S; Mutimer, D; Gane, E; Moreno, C; Tsung Chang, T; Lee, SS; Marinho, R; Dufour, Jean-François; Pol, S; Hezode, C; Gordon, SC; Strasser, SI; Thuluvath, PJ; Liu, R; Pilot-Matias, T; Mensa, F (14 September 2017). High SVR Rates with 8 and 12 Weeks of Pangenotypic GlecapreviriPibrentasvir: PH2 Integrated Efficacy and Safety Analysis of Genotype 1-6 Patients without Cirrhosis. Swiss medical weekly, 147(Suppl 225), p. 20. EMH Schweizerischer Ärzteverlag

Kachaylo, Ekaterina; Tschuor, Christoph; Calo, Nicolas; Borgeaud, Nathalie; Ungethüm, Udo; Limani, Perparim; Piguet, Anne Christine; Dufour, Jean-François; Foti, Michelangelo; Graf, Rolf; Clavien, Pierre A; Humar, Bostjan (2017). PTEN Down-Regulation Promotes β-Oxidation to Fuel Hypertrophic Liver Growth After Hepatectomy in Mice. Hepatology, 66(3), pp. 908-921. Wiley Interscience 10.1002/hep.29226

von Köckritz, Leona Isabella; Dufour, Jean-François (2017). Management of chronic hepatitis C in 2017. Hämostaseologie, 37(3), pp. 186-195. Schattauer 10.5482/HAMO-16-07-0019

Linecker, Michael; Limani, Perparim; Kambakamba, Patryk; Kron, Philipp; Tschuor, Christoph; Calo, Nicolas; Foti, Michelangelo; Dufour, Jean-François; Graf, Rolf; Humar, Bostjan; Clavien, Pierre-Alain (2017). Omega-3 Fatty Acids Protect Fatty and Lean Mouse Livers After Major Hepatectomy. Annals of surgery, 266(2), pp. 324-332. Lippincott Williams & Wilkins 10.1097/SLA.0000000000001968

Segna, Daniel; Dufour, Jean-François (2017). Other Extrahepatic Manifestations of Hepatitis C Virus Infection (Pulmonary, Idiopathic Thrombocytopenic Purpura, Nondiabetes Endocrine Disorders). Clinics in Liver Disease, 21(3), pp. 607-629. Elsevier 10.1016/j.cld.2017.03.014

Rauh, Christina; Dufour, Jean-François (2017). Nichtalkoholische Fettlebererkrankung (NAFLD). Therapeutische Umschau, 74(3), pp. 87-92. Huber 10.1024/0040-5930/a000890

Dufour, Jean-François (2017). Hepatology Highlights. Hepatology, 65(6), pp. 1783-1784. Wiley Interscience 10.1002/hep.29210

Perazzo, Hugo; Dufour, Jean-François (2017). The therapeutic landscape of non-alcoholic steatohepatitis. Liver international, 37(5), pp. 634-647. Wiley 10.1111/liv.13270

McPherson, Stuart; Hardy, Tim; Dufour, Jean-François; Petta, Salvatore; Romero-Gomez, Manuel; Allison, Mike; Oliveira, Claudia P; Francque, Sven; Van Gaal, Luc; Schattenberg, Jörn M; Tiniakos, Dina; Burt, Alastair; Bugianesi, Elisabetta; Ratziu, Vlad; Day, Christopher P; Anstee, Quentin M (2017). Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis. The American journal of gastroenterology, 112(5), pp. 740-751. Nature Publishing Group 10.1038/ajg.2016.453

Dufour, Jean-François (2017). Hepatology Highlights. Hepatology, 65(5), pp. 1429-1431. Wiley Interscience 10.1002/hep.29149

Dufour, Jean-François (2017). Hepatology Highlights. Hepatology, 65(4), pp. 1081-1083. Wiley Interscience 10.1002/hep.29123

Lévy, Pierre L.; Duponchel, Sarah; Eischeid, Hannah; Molle, Jennifer; Michelet, Maud; Diserens, Gaëlle; Vermathen, Martina; Vermathen, Peter; Dufour, Jean-François; Dienes, Hans-Peter; Steffen, Hans-Michael; Odenthal, Margarete; Zoulim, Fabien; Bartosch, Birke (2017). Hepatitis C virus infection triggers a tumor-like glutamine metabolism. Hepatology, 65(3), pp. 789-803. Wiley Interscience 10.1002/hep.28949

Kolly, Philippe; Dufour, Jean-François (2017). Patients with hepatocellular carcinoma: Your address matters! Journal of hepatology, 66(3), pp. 480-481. Elsevier 10.1016/j.jhep.2016.11.026

Dufour, Jean-François (2017). Hepatology Highlights. Hepatology, 65(3), pp. 761-762. Wiley Interscience 10.1002/hep.29044

Dufour, Jean-François (2017). Hepatology Highlights. Hepatology, 65(2), pp. 399-400. Wiley Interscience 10.1002/hep.28997

Herrmann, Evelyn; Naehrig, Diana; Sassowsky, Manfred; Bigler, Martin; Buijsen, Jeroen; Ciernik, Ilja; Zwahlen, Daniel; Pellanda, Alessandra Franzetti; Meister, Andreas; Brauchli, Peter; Berardi, Simona; Kuettel, Erika; Dufour, Jean-François; Aebersold, Daniel; Swiss Group for Clinical Cancer Research, SAKK (2017). External beam radiotherapy for unresectable hepatocellular carcinoma, an international multicenter phase I trial, SAKK 77/07 and SASL 26. Radiation oncology, 12(1), p. 12. BioMed Central 10.1186/s13014-016-0745-0

Hari, Andrej; Nair, Harikumar; De Gottardi, Andrea; Baumgartner, Iris; Dufour, Jean-François; Berzigotti, Annalisa (2017). Diagnostic hepatic haemodynamic techniques: safety and radiation exposure. Liver international, 37(1), pp. 148-154. Wiley 10.1111/liv.13215

Tapper, Elliot B; Hughes, Michael S; Buti, Maria; Dufour, Jean-François; Flamm, Steve; Firdoos, Saima; Curry, Michael P; Afdhal, Nezam H (2017). The optimal timing of hepatitis C therapy in transplant eligible patients with Child B and C Cirrhosis: A Cost-Effectiveness Analysis. Transplantation, 101(5), pp. 987-995. Lippincott Williams & Wilkins 10.1097/TP.0000000000001400

Dufour, Jean-François (2016). Hepatology Highlights. Hepatology, 64(6), pp. 1829-1830. Wiley Interscience 10.1002/hep.28867

Dufour, Jean-François (2016). Hepatology Highlights. Hepatology, 64(5), pp. 1395-1397. Wiley Interscience 10.1002/hep.28828

Calo, Nicolas; Ramadori, Pierluigi; Sobolewski, Cyril; Romero, Yannick; Maeder, Christine; Fournier, Margot; Rantakari, Pia; Zhang, Fu-Ping; Poutanen, Matti; Dufour, Jean-François; Humar, Bostjan; Nef, Serge; Foti, Michelangelo (2016). Stress-activated miR-21/miR-21* in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption. Gut, 65(11), pp. 1871-1881. BMJ Publishing Group 10.1136/gutjnl-2015-310822

Maan, Raoel; Zaim, Remziye; van der Meer, Adriaan J; Feld, Jordan J; Wedemeyer, Heiner; Dufour, Jean-François; Lammert, Frank; Manns, Michael P; Zeuzem, Stefan; Hansen, Bettina E; Janssen, Harry LA; Veldt, Bart J; de Knegt, Robert J; Uyl-de Groot, Carin A (2016). Real-world medical costs of antiviral therapy among patients with chronic HCV infection and advanced hepatic fibrosis. Journal of gastroenterology and hepatology, 31(11), pp. 1851-1859. Wiley-Blackwell Publishing Asia 10.1111/jgh.13373

Llovet, J; Merle, P; Weiss, KH; Yau, T; Ross, P; Mazzaferro, V; Blanc, JF; Ma, Y; Yen, C; Kocsis, J; Choo, S; Sukeepaisarnjaroen, W; Gerolami, R; Dufour, Jean-François; Gane, E; Ryoo, BY; Peck, M; Dao, T; Yeo, W; Lamlertthon, W; ... (November 2016). Phase II Studies with Refametinib or Refametinib Plus Sorafenib in Patients with Mutant RAS Hepatocellular Carcinoma (HCC). Hepatology, 64(1Suppl), 621A-621A. Wiley Interscience

Munteanu, M.; Tiniakos, D.; Anstee, Q.; Charlotte, F.; Marchesini, G.; Bugianesi, E.; Trauner, M.; Oliveira, C.; Day, C.; Dufour, Jean-François; Bellentani, S.; Ngo, Y.; Traussnig, S.; Bedossa, P.; Ratziu, V.; Poynard, T. (November 2016). Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference. Hepatology, 64(S1), 585A-585A. Wiley Interscience

Dufour, Jean-François (2016). Hepatology Highlights. Hepatology, 64(4), pp. 1011-1013. Wiley Interscience 10.1002/hep.28764

Giudici, F; Bertisch, B; Negro, F; Stirnimann, G; Müllhaupt, B; Moradpour, D; Cerny, A; Dufour, Jean-François; Keiser, O (2016). Access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study: a person-centred approach. Journal of viral hepatitis, 23(9), pp. 697-707. Blackwell Science 10.1111/jvh.12535

Teufel, Andreas; Itzel, Timo; Erhart, Wiebke; Brosch, Mario; Wang, Xiao Yu; Kim, Yong Ook; von Schönfels, Witigo; Herrmann, Alexander; Brückner, Stefan; Stickel, Felix; Dufour, Jean-François; Chavakis, Triantafyllos; Hellerbrand, Claus; Spang, Rainer; Maass, Thorsten; Becker, Thomas; Schreiber, Stefan; Schafmayer, Clemens; Schuppan, Detlef and Hampe, Jochen (2016). Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients. Gastroenterology, 151(3), pp. 513-525. Elsevier 10.1053/j.gastro.2016.05.051

Dufour, Jean-François (2016). Hepatology Highlights. Hepatology, 64(3), pp. 703-705. Wiley Interscience 10.1002/hep.28725

Teufel, Andreas; Dufour, Jean-François (2016). Two-Step Forward Genetic Screen in Mice Identifies the Ral Pathway as a Central Drug Target in Hepatocellular Carcinoma. Gastroenterology, 151(2), pp. 231-233. Elsevier 10.1053/j.gastro.2016.06.034

Zeuzem, Stefan; Mantry, Parvez; Soriano, Vicente; Buynak, Robert J; Dufour, Jean-François; Pockros, Paul J; Wright, David; Angus, Peter; Buti, Maria; Stern, Jerry O; Kadus, Werner; Vinisko, Richard; Böcher, Wulf; Mensa, Federico J (2016). Short article: Faldaprevir, deleobuvir and ribavirin in IL28B non-CC patients with HCV genotype-1a infection included in the SOUND-C3 phase 2b study. European journal of gastroenterology & hepatology, 28(8), pp. 923-926. Lippincott Williams & Wilkins 10.1097/MEG.0000000000000649

Dufour, Jean-François (2016). Hepatology Highlights. Hepatology, 64(2), pp. 325-327. Wiley Interscience 10.1002/hep.28683

Zahnd, Cindy; Salazar-Vizcaya, Luisa; Dufour, Jean-François; Müllhaupt, Beat; Wandeler, Gilles; Kouyos, Roger; Estill, Janne; Bertisch, Barbara; Rauch, Andri; Keiser, Olivia (2016). Modelling the impact of deferring HCV treatment on liver-related complications in HIV coinfected men who have sex with men. Journal of hepatology, 65(1), pp. 26-32. Elsevier 10.1016/j.jhep.2016.02.030

Dufour, Jean-François (2016). Hepatology Highlights. Hepatology, 64(1), pp. 1-3. Wiley Interscience 10.1002/hep.28645

Manns, Michael; Samuel, Didier; Gane, Edward J; Mutimer, David; McCaughan, Geoff; Buti, Maria; Prieto, Martín; Calleja, José Luis; Peck-Radosavljevic, Markus; Müllhaupt, Beat; Agarwal, Kosh; Angus, Peter; Yoshida, Eric M; Colombo, Massimo; Rizzetto, Mario; Dvory-Sobol, Hadas; Denning, Jill; Arterburn, Sarah; Pang, Phillip S; Brainard, Diana; ... (2016). Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial. Lancet infectious diseases, 16(6), pp. 685-697. Elsevier 10.1016/S1473-3099(16)00052-9

Dufour, Jean-François (2016). Hepatology highlights. Hepatology, 63(6), pp. 1749-1751. Wiley Interscience 10.1002/hep.28605

Koeberle, D; Dufour, Jean-François; Demeter, G; Li, Q; Ribi, K; Samaras, P; Saletti, P; Roth, A D; Horber, D; Bühlmann, Michael; Wagner, A D; Montemurro, M; Lakatos, G; Feilchenfeldt, J; Peck-Radosavljevic, M; Rauch, D; Tschanz, B; Bodoky, G; Swiss Group for Clinical Cancer, SAKK (2016). Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29). Annals of oncology, 27(5), pp. 856-861. Oxford University Press 10.1093/annonc/mdw054

Dufour, Jean-François (2016). Hepatology highlights. Hepatology, 63(5), pp. 1405-1407. Wiley Interscience 10.1002/hep.28566

Martin, Juliette; Balmer, Maria Luisa; Rajendran, Saranya; Maurhofer, Olivier; Dufour, Jean-François; St-Pierre Dufour, Marie Vivien (2016). Nutritional stress exacerbates hepatic steatosis induced by deletion of the histidine nucleotide-binding (Hint2) mitochondrial protein. American journal of physiology - gastrointestinal and liver physiology, 310(7), G497-509. American Physiological Society 10.1152/ajpgi.00178.2015

Dufour, Jean-François (2016). Hepatology highlights. Hepatology, 63(4), pp. 1065-1067. Wiley Interscience 10.1002/hep.28498

Margini, Cristina; Dufour, Jean-François (2016). The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment. Liver international, 36(3), pp. 317-324. Blackwell Munksgaard 10.1111/liv.13031

Foster, G R; Ferenci, P; Asselah, T; Mantry, P; Dufour, Jean-François; Dufour, Jean-François; Bourlière, M; Forton, D; Maevskaya, M; Wright, D; Yoshida, E M; García-Samaniego, J; Oliveira, C; Wright, M; Warner, N; Sha, N; Quinson, A-M; Stern, J O (2016). Open-label study of faldaprevir plus peginterferon and ribavirin in hepatitis C virus genotype 1-infected patients who failed placebo plus peginterferon and ribavirin. Journal of viral hepatitis, 23(3), pp. 227-231. Blackwell Science 10.1111/jvh.12485

Dufour, Jean-François (2016). Hepatology highlights. Hepatology, 63(3), pp. 679-681. Wiley Interscience 10.1002/hep.28454

Dufour, Jean-François (2016). Hepatology highlights. Hepatology, 63(2), pp. 351-353. Wiley Interscience 10.1002/hep.28402

Saran, Uttara; Humar, Bostjan; Kolly, Philippe; Dufour, Jean-François (2016). Hepatocellular carcinoma and lifestyles. Journal of hepatology, 64(1), pp. 203-214. Elsevier 10.1016/j.jhep.2015.08.028

Richani, Mandy; Kolly, Philippe; Knoepfli, Marina; Herrmann, Evelyn; Zweifel, Martin; Von Tengg-Kobligk, Hendrik; Candinas, Daniel; Dufour, Jean-François (2016). Treatment allocation in hepatocellular carcinoma: Assessment of the BCLC algorithm. Annals of hepatology, 15(1), pp. 82-90. Sociedad Mexicana de Hepatologia

Bechtel-Grosch, Ursina; Béguelin, Charles Antoine; Berezowska, Sabina Anna; Dufour, Jean-François; Takala, Jukka; Schefold, Joerg C. (2016). Fulminant hepatic and multiple organ failure following acute viral tonsillitis: a case report. Journal of medical case reports, 10(7), p. 7. BioMed Central 10.1186/s13256-015-0777-3

Kolly, Philippe; Dufour, Jean-François (2016). Reply to «Lack of evidence of an effect of Direct Acting Antivirals on the recurrence of hepatocellular carcinoma: The ANRS collaborative study group on hepatocellular carcinoma (ANRS CO22 HEPATHER, CO12 CIRVIR and CO23 CUPILT cohorts)». Journal of hepatology, 65(6), pp. 1268-1269. Elsevier 10.1016/j.jhep.2016.07.032

Kolly, Philippe; Dufour, Jean-François (2016). Surveillance for Hepatocellular Carcinoma in Patients with NASH. Diagnostics, 6(2), p. 22. MDPI 10.3390/diagnostics6020022

Munteanu, M.; Tiniakos, D.; Anstee, Q.; Charlotte, F.; Marchesini, G.; Bugianesi, E.; Trauner, M.; Romero Gomez, M.; Oliveira, C.; Day, C.; Dufour, Jean-François; Bellentani, S.; Ngo, Y.; Traussnig, S.; Perazzo, H.; Deckmyn, O.; Bedossa, P.; Ratziu, V.; Poynard, T. (2016). Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference. Alimentary pharmacology & therapeutics, 44(8), pp. 877-889. Wiley-Blackwell 10.1111/apt.13770

Scherer, Antonia; Dufour, Jean-François (2016). Treatment of Non-Alcoholic Fatty Liver Disease. Digestive diseases, 34(Suppl. 1), pp. 27-31. Karger 10.1159/000447278

Buhler, Stéphane; Giostra, Emiliano; Gbame, Corinne; de Rham, Casimir; Mullhaupt, Beat; Dufour, Jean-François; Majno, Pietro; Negro, Francesco; Bochud, Pierre-Yves; Villard, Jean (2015). A significant effect of the KIR ligand HLA-C on fibrosis progression in chronic C hepatitis with or without liver transplantation. Liver international, 36(9), n/a-n/a. Blackwell Munksgaard 10.1111/liv.13057

Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 63(1), pp. 1-3. Wiley Interscience 10.1002/hep.28354

Kolly, Philippe; Reeves, Helen; Sangro, Bruno; Knöpfli, Marina Janusheva; Candinas, Daniel; Dufour, Jean-François (2015). Assessment of the Hong Kong Liver Cancer Staging System in Europe. Liver international, 36(6), pp. 911-917. Blackwell Munksgaard 10.1111/liv.13045

Quteineh, L; Bochud, P-Y; Golshayan, D; Crettol, S; Venetz, J-P; Manuel, O; Kutalik, Z; Treyer, A; Lehmann, R; Mueller, N J; Binet, I; van Delden, C; Steiger, J; Mohacsi, P; Dufour, Jean-François; Soccal, P M; Pascual, M; Semmo, Nasser; Beldi, Guido and Eap, C B (2015). CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation. Pharmacogenomics journal, 17(1), pp. 69-75. Nature Publishing Group 10.1038/tpj.2015.82

van der Meer, Adriaan J; Maan, Raoel; Veldt, Bart J; Feld, Jordan J; Wedemeyer, Heiner; Dufour, Jean-François; Lammert, Frank; Duarte-Rojo, Andres; Manns, Michael P; Zeuzem, Stefan; Peter Hofmann, W; de Knegt, Robert J; Hansen, Bettina E; Janssen, Harry L A (2015). Improvement of platelets after SVR among patients with chronic HCV infection and advanced hepatic fibrosis. Journal of gastroenterology and hepatology, 31(6), pp. 1168-1176. Wiley-Blackwell Publishing Asia 10.1111/jgh.13252

Wang, Qixia; Sachse, Karl Philip; Semmo, M; Lokhande, Megha; Montani, Matteo; Dufour, Jean-François; Zoulim, F; Klenerman, Paul; Semmo, Nasser (2015). T- and B-cell responses and previous exposure to hepatitis B virus in 'anti-HBc alone' patients. Journal of viral hepatitis, 22(12), pp. 1068-1078. Blackwell Science 10.1111/jvh.12428

Bartella, Isabel; Dufour, Jean-François (2015). Clinical Diagnosis and Staging of Intrahepatic Cholangiocarcinoma. Journal of gastrointestinal and liver diseases, 24(4), pp. 481-489. Medical University Press 10.15403/jgld.2014.1121.244.chl

Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 62(6), pp. 1649-1651. Wiley Interscience 10.1002/hep.28288

Saran, Uttara; Foti, Michelangelo; Dufour, Jean-François (2015). Cellular and molecular effects of the mTOR inhibitor everolimus. Clinical science, 129(10), pp. 895-914. Portland 10.1042/CS20150149

Wang, Hui; El Maadidi, Souhayla; Fischer, Janett; Grabski, Elena; Dickhöfer, Sabine; Klimosch, Sascha; Flannery, Sinead M; Filomena, Angela; Wolz, Olaf-Oliver; Schneiderhan-Marra, Nicole; Löffler, Markus W; Wiese, Manfred; Pichulik, Tica; Müllhaupt, Beat; Semela, David; Dufour, Jean-François; Bochud, Pierre-Yves; Bowie, Andrew G; Kalinke, Ulrich; Berg, Thomas; ... (2015). A frequent hypofunctional IRAK2 variant is associated with reduced spontaneous hepatitis C virus clearance. Hepatology, 62(5), pp. 1375-1387. Wiley Interscience 10.1002/hep.28105

Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 62(5), pp. 1331-1333. Wiley Interscience 10.1002/hep.28161

Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 62(4), pp. 985-987. Wiley Interscience 10.1002/hep.28127

Berzigotti, Annalisa; Saran, Uttara; Dufour, Jean-François (2015). Physical activity and liver diseases. Hepatology, 63(3), pp. 1026-1040. Wiley Interscience 10.1002/hep.28132

Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 62(3), pp. 663-665. Wiley Interscience 10.1002/hep.27995

Pocha, Christine; Kolly, Philippe; Dufour, Jean-François (2015). Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: A Problem of Growing Magnitude. Seminars in liver disease, 35(3), pp. 304-317. Thieme Medical Publishers 10.1055/s-0035-1562949

Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 62(2), pp. 327-329. Wiley Interscience 10.1002/hep.27933

Piguet, Anne-Christine; Medova, Michaela; Keogh, Adrian; Glück, Astrid Andreina; Aebersold, Daniel; Dufour, Jean-François; Dufour, Jean-François; Zimmer, Yitzhak (2015). Impact of MET targeting on tumor-associated angiogenesis and growth of MET mutations-driven models of liver cancer. Genes & cancer, 6(7-8), pp. 317-327. Impact Journals

Zhu, Andrew X; Park, Joon Oh; Ryoo, Baek-Yeol; Yen, Chia-Jui; Poon, Ronnie; Pastorelli, Davide; Blanc, Jean-Frederic; Chung, Hyun Cheol; Baron, Ari D; Pfiffer, Tulio Eduardo Flesch; Okusaka, Takuji; Kubackova, Katerina; Trojan, Jorg; Sastre, Javier; Chau, Ian; Chang, Shao-Chun; Abada, Paolo B; Yang, Ling; Schwartz, Jonathan D; Kudo, Masatoshi; ... (2015). Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial. The lancet oncology, 16(7), pp. 859-870. Elsevier 10.1016/S1470-2045(15)00050-9

Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 62(1), pp. 1-3. Wiley Interscience 10.1002/hep.27898

Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 61(6), pp. 1773-1775. Wiley Interscience 10.1002/hep.27848

Dufour, Jean-François (2015). Hepatology highlights. Hepatology, 61(5), pp. 1449-1451. Wiley Interscience 10.1002/hep.27788

Toso, Christian; Meeberg, Glenda; Hernandez-Alejandro, Roberto; Dufour, Jean-François; Marotta, Paul; Majno, Pietro; Kneteman, Norman M (2015). Total Tumor Volume and Alpha Fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation. Hepatology, 62(1), pp. 158-165. Wiley Interscience 10.1002/hep.27787

Maan, Raoel; van der Meer, Adriaan J; Hansen, Bettina E; Feld, Jordan J; Wedemeyer, Heiner; Dufour, Jean-François; Lammert, Frank; Manns, Michael P; Zeuzem, Stefan; Janssen, Harry L A; de Knegt, Robert J; Veldt, Bart J (2015). Risk of infections during interferon-based treatment in patients with chronic HCV infection and advanced hepatic fibrosis. Journal of gastroenterology and hepatology, 30(6), pp. 1057-1064. Wiley-Blackwell Publishing Asia 10.1111/jgh.12929

van der Meer, Adriaan J; Hansen, Bettina E; Fattovich, Giovanna; Feld, Jordan J; Wedemeyer, Heiner; Dufour, Jean-François; Lammert, Frank; Duarte-Rojo, Andres; Manns, Michael P; Ieluzzi, Donatella; Zeuzem, Stefan; Hofmann, W Peter; de Knegt, Robert J; Veldt, Bart J; Janssen, Harry L A (2015). Reliable prediction of clinical outcome in patients with chronic HCV infection and compensated advanced hepatic fibrosis: a validated model using objective and readily available clinical parameters. Gut, 64(2), pp. 322-331. BMJ Publishing Group 10.1136/gutjnl-2013-305357

Zeuzem, Stefan; Dufour, Jean-François; Buti, Maria; Soriano, Vicente; Buynak, Robert J; Mantry, Parvez; Taunk, Jawahar; Stern, Jerry O; Vinisko, Richard; Gallivan, John-Paul; Böcher, Wulf; Mensa, Federico J (2015). Interferon-free treatment of chronic hepatitis C with faldaprevir, deleobuvir and ribavirin: SOUND-C3, a Phase 2b study. Liver international, 35(2), pp. 417-421. Blackwell Munksgaard 10.1111/liv.12693

Piguet, Anne Christine; Saran, Uttara; Simillion, Cedric André Marie; Keller, Irene; Terracciano, Luigi; Reeves, Helen L; Dufour, Jean-François (2015). Regular exercise decreases liver tumors development in hepatocyte-specific PTEN-deficient mice independently of steatosis. Journal of hepatology, 62(6), pp. 1296-1303. Elsevier 10.1016/j.jhep.2015.01.017

Diserens, Gaëlle; Vermathen, Martina; Precht, Maria Christina; Broskey, N T; Boesch, Chris; Amati, F; Dufour, Jean-François; Vermathen, Peter (2015). Separation of small metabolites and lipids in spectra from biopsies by diffusion-weighted HR-MAS NMR: a feasibility study. The Analyst, 140(1), pp. 272-279. Royal Society of Chemistry 10.1039/c4an01663g

Ferenci, Peter; Asselah, Tarik; Foster, Graham R; Zeuzem, Stefan; Sarrazin, Christoph; Moreno, Christophe; Ouzan, Denis; Maevskaya, Marina; Calinas, Filipe; Morano, Luis E; Crespo, Javier; Dufour, Jean-François; Bourlière, Marc; Agarwal, Kosh; Forton, Daniel; Schuchmann, Marcus; Zehnter, Elmar; Nishiguchi, Shuhei; Omata, Masao; Kukolj, George; ... (2015). STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection. Journal of hepatology, 62(6), pp. 1246-1255. Elsevier 10.1016/j.jhep.2014.12.024

Zochowska, Monika; Piguet, Anne Christine; Jemielity, Jacek; Kowalska, Joanna; Szolajska, Ewa; Dufour, Jean-François; Chroboczek, Jadwiga (2015). Virus-like particle-mediated intracellular delivery of mRNA cap analog with in vivo activity against hepatocellular carcinoma. Nanomedicine : nanotechnology, biology, and medicine, 11(1), pp. 67-76. Elsevier 10.1016/j.nano.2014.07.009

Wandeler, Gilles; Dufour, Jean-François; Bruggmann, Philip; Rauch, Andri (2015). Hepatitis C: a changing epidemic. Swiss medical weekly, 145, w14093. EMH Schweizerischer Ärzteverlag 10.4414/smw.2015.14093

Hirzel, Cédric; Wandeler, Gilles; Owczarek, Marta; Gorgievski, Meri; Dufour, Jean-François; Semmo, Nasser; Zürcher, Samuel (2015). Molecular epidemiology of hepatitis B virus infection in Switzerland: a retrospective cohort study. BMC infectious diseases, 15(1), p. 483. BioMed Central 10.1186/s12879-015-1234-z

van der Meer, Adriaan J; Wedemeyer, Heiner; Feld, Jordan J; Dufour, Jean-François; Zeuzem, Stefan; Hansen, Bettina E; Janssen, Harry L A (2014). Life expectancy in patients with chronic HCV infection and cirrhosis compared with a general population. JAMA : the journal of the American Medical Association, 312(18), pp. 1927-1928. American Medical Association 10.1001/jama.2014.12627

Beyoglu, Diren; Krausz, K. W.; Martin, Juliette; Maurhofer, Olivier; Dorow, J.; Ceglarek, U.; Gonzalez, F. J.; Dufour, Jean-François; Idle, Jeffrey (2014). Disruption of tumor suppressor gene Hint1 leads to remodeling of the lipid metabolic phenotype of mouse liver. Journal of lipid research, 55(11), pp. 2309-2319. American Society for Biochemistry and Molecular Biology ASBMB 10.1194/jlr.M050682

Dufour, Jean-François (October 2014). Impact of Lifestyle on NAFLD (Unpublished). In: UEG Annual Meeting. Wien. October 2014.

Dufour, Jean-François (October 2014). Hepatocellular carcinoma: what is new in 2014 (Unpublished). In: UEG Annual Meeting. Wien. October 2014.

Rüeger, S; Bochud, P-Y; Dufour, Jean-François; Müllhaupt, B; Semela, D; Heim, M H; Moradpour, D; Cerny, A; Malinverni, R; Booth, D R; Suppiah, V; George, J; Argiro, L; Halfon, P; Bourlière, M; Talal, A H; Jacobson, I M; Patin, E; Nalpas, B; Poynard, T; ... (2014). Impact of common risk factors of fibrosis progression in chronic hepatitis C. Gut, 64(10), pp. 1605-1615. BMJ Publishing Group 10.1136/gutjnl-2014-306997

Maan, Raoel; van der Meer, Adriaan J; Hansen, Bettina E; Feld, Jordan J; Wedemeyer, Heiner; Dufour, Jean-François; Zangneh, Hooman F; Lammert, Frank; Manns, Michael P; Zeuzem, Stefan; Janssen, Harry L A; de Knegt, Robert J; Veldt, Bart J (2014). Effect of thrombocytopenia on treatment tolerability and outcome in patients with chronic HCV infection and advanced hepatic fibrosis. Journal of hepatology, 61(3), pp. 482-491. Elsevier 10.1016/j.jhep.2014.04.021

Dufour, Jean-François (September 2014). TACE: Who, When, How and How to evaluate? (Unpublished). In: HCC Day. Lausanne. September 2014.

Dufour, Jean-François (August 2014). Directly acting antivirals for the treatment of hepatitis C: key messages from phase III tri-als’. (Unpublished). In: Swiss Society for Infectious Diseases. Aarau. August 2014.

Liu, Y-L; Patman, G L; Leathart, J B S; Piguet, Anne Christine; Burt, A D; Dufour, Jean-François; Day, C P; Daly, A K; Reeves, H L; Anstee, Q M (2014). Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma. Journal of hepatology, 61(1), pp. 75-81. Elsevier 10.1016/j.jhep.2014.02.030

Dufour, Jean-François (June 2014). The ABC of viral Hepatitis (Unpublished). In: UEG Summer school. Prague. June 2014.

Dufour, Jean-François (2014). Hepatocellular carcinoma: sorafenib: for once age is not an issue. Nature reviews - gastroenterology & hepatology, 11(5), pp. 273-274. Nature Publishing Group 10.1038/nrgastro.2014.48

Frei, Pascal; Leucht, Anna-Kathrin; Held, Ulrike; Kofmehl, Reto; Manser, Christine N.; Schmitt, Johannes; Mertens, Joachim; Rau, Monika; Baur, Katharina; Gerlach, Tilman; Negro, Francesco; Heim, Markus; Moradpour, Darius; Cerny, Andreas; Dufour, Jean-François; Müllhaupt, Beat; Geier, Andreas (2014). Elderly age is not a negative predictive factor for virological response to therapy with pegylated interferon-α and ribavirin in chronic hepatitis C virus patients. Liver international, 34(4), pp. 551-557. Blackwell Munksgaard 10.1111/liv.12279

Patsenker, Eleanora; Sachse, Philip; Mattsson, Johan; Lanz, Christian; Schneider, Vreni; Brenneisen, Rudolf Max; De Gottardi, Andrea; Dufour, Jean-François; Stickel, Felix; Semmo, Nasser (April 2014). Endocannabinoids Suppress Cytokine Secretion in HCV Infection (Unpublished). In: EASL International Liver Congress 2014. London, UK. 09.-13.04.2014.

De Gottardi, Andrea; Banz Wüthrich, Vanessa; Storni, Federico; Stirnimann, Guido; Semmo, Nasser; Engelmann, C; Piguet, Anne Christine; Whittaker, S; Lammert, F; Berg, T; Zeuzern, S; Cordoba, J; Dufour, Jean-François (April 2014). Safety and Efficacy of an Automated Low Flow Ascites (alfa) Pump in Cirrhotic Patients with Refractory Ascites. In: EASL International Liver Congress 2014. London, UK. 09.-13.04.2014.

Dufour, Jean-François (February 2014). HCC: combination local-systemic therapies (Unpublished). In: EASL Monothematic Conference. Geneva. February 2014.

Al Hasani, Farah; Knoepfli, Marina; Gemperli, Armin; Kollár, Attila; Banz, Vanessa; Kettenbach, Joachim; Jüni, Peter; Dufour, Jean-François (2014). Factors affecting screening for hepatocellular carcinoma. Annals of hepatology, 13(2), pp. 204-210. Sociedad Mexicana de Hepatologia

Piguet, Anne Christine; Majumder, Syamantak; Maheshwari, Uma; Manjunathan, Reji; Saran, Uttara; Chatterjee, Suvro; Dufour, Jean-François (2014). Everolimus is a potent inhibitor of activated hepatic stellate cell functions in vitro and in vivo , while demonstrating anti-angiogenic activities. Clinical science, 126(11), pp. 775-784. Portland 10.1042/CS20130081

Perazzo, Hugo; Poynard, Thierry; Dufour, Jean-François; Dufour, Jean-François (2014). The Interactions of Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases. Clinics in Liver Disease, 18(1), pp. 233-248. Elsevier 10.1016/j.cld.2013.09.014

Terczyńska-Dyla, Ewa; Bibert, Stephanie; Duong, Francois H. T.; Krol, Ilona; Jørgensen, Sanne; Collinet, Emilie; Kutalik, Zoltán; Aubert, Vincent; Cerny, Andreas; Kaiser, Laurent; Malinverni, Raffaele; Mangia, Alessandra; Moradpour, Darius; Müllhaupt, Beat; Negro, Francesco; Santoro, Rosanna; Semela, David; Semmo, Nasser; Rubbia-Brandt, Laura; Martinetti, Gladys; ... (2014). Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes. Nature communications, 5, p. 5699. Nature Publishing Group 10.1038/ncomms6699

Liu, Yang-Lin; Reeves, Helen L; Burt, Alastair D; Tiniakos, Dina; McPherson, Stuart; Leathart, Julian B S; Allison, Michael E D; Alexander, Graeme J; Piguet, Anne Christine; Anty, Rodolphe; Donaldson, Peter; Aithal, Guruprasad P; Francque, Sven; Van Gaal, Luc; Clement, Karine; Ratziu, Vlad; Dufour, Jean-François; Day, Christopher P; Daly, Ann K and Anstee, Quentin M (2014). TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease. Nature communications, 5(4309), p. 4309. Nature Publishing Group 10.1038/ncomms5309

Dufour, Jean-François (2014). Liver Cancer in Metabolic Diseases (Unpublished). In: UEG Single Topic Conference. Birmingham.

Erös de Bethlenfalva - Hora, Caroline; Mertens, Joachim C.; Piguet, Anne Christine; Kettenbach, Joachim; Schmitt, Johannes; Terracciano, Luigi; Weimann, Rosemarie; Dufour, Jean-François; Geier, Andreas (2014). Radiofrequency ablation suppresses distant tumour growth in a novel rat model of multifocal hepatocellular carcinoma. Clinical science, 126(3), pp. 243-252. Portland 10.1042/CS20130089

Dufour, Jean-François (2013). Hepatology Highlights. Hepatology, 58(6), pp. 1869-1870. Wiley Interscience 10.1002/hep.26780

Ndiaye, Dieynaba; Collado-Hilly, Mauricette; Martin, Juliette; Prigent, Sylvie; Dufour, Jean-François; Combettes, Laurent; Dupont, Geneviève (2013). Characterization of the Effect of the Mitochondrial Protein Hint2 on Intracellular Ca2+ dynamics. Biophysical journal, 105(5), pp. 1268-1275. Biophysical Society 10.1016/j.bpj.2013.06.048

Beyoglu, Diren; Imbeaud, Sandrine; Maurhofer, Olivier; Bioulac-Sage, Paulette; Zucman-Rossi, Jessica; Dufour, Jean-François; Idle, Jeffrey R. (2013). Tissue metabolomics of hepatocellular carcinoma: Tumor energy metabolism and the role of transcriptomic classification. Hepatology, 58(1), pp. 229-238. Wiley Interscience 10.1002/hep.26350

Bibert, Stéphanie; Roger, Thierry; Calandra, Thierry; Bochud, Murielle; Cerny, Andreas; Semmo, Nasser; Duong, François H. T.; Gerlach, Tilman; Malinverni, Raffaele; Moradpour, Darius; Negro, Francesco; Müllhaupt, Beat; Bochud, Pierre-Yves; Swiss Hepatitis C Cohort Study, the; Dufour, Jean-François (2013). IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction. Journal of experimental medicine, 210(6), pp. 1109-1116. Rockefeller University Press 10.1084/jem.20130012

Leichtle, Alexander Benedikt; Dufour, Jean-François; Fiedler, Martin (2013). Potentials and pitfalls of clinical peptidomics and metabolomics. Swiss medical weekly, 143, w13801. EMH Schweizerischer Ärzteverlag 10.4414/smw.2013.13801

Röther, Mareike; Dufour, Jean-François; Schnüriger, Beat (2013). An Uncommon Cause of a Focal Liver Lesion. Gastroenterology, 144(3), pp. 510-659. Elsevier 10.1053/j.gastro.2012.10.017

van der Meer, A. J.; Veldt, B. J.; Feld, J. J.; Wedemeyer, H.; Dufour, Jean-François; Lammert, F.; Duarte-Rojo, A.; Manns, M. P.; Zeuzem, S.; Hofmann, W. P.; de Knegt, R. J.; Hansen, B. E.; Janssen, H. L. A. (2013). The number needed to treat to prevent mortality and cirrhosis-related complications among patients with cirrhosis and HCV genotype 1 infection. Journal of viral hepatitis, 21(8), pp. 568-577. Blackwell Science 10.1111/jvh.12185

Tonko, Sebastian; Dufour, Jean-François (2013). Hepatologische Scores. Therapeutische Umschau, 70(10), pp. 577-579. Huber 10.1024/0040-5930/a000450

Lange, Christian M.; Miki, Daiki; Ochi, Hidenori; Nischalke, Hans-Dieter; Bojunga, Jörg; Bibert, Stéphanie; Morikawa, Kenichi; Gouttenoire, Jérôme; Cerny, Andreas; Dufour, Jean-François; Gorgievski, Meri; Heim, Markus H.; Malinverni, Raffaele; Müllhaupt, Beat; Negro, Francesco; Semela, David; Kutalik, Zoltan; Müller, Tobias; Spengler, Ulrich; Berg, Thomas; ... (2013). Genetic Analyses Reveal a Role for Vitamin D Insufficiency in HCV-Associated Hepatocellular Carcinoma Development. PLoS ONE, 8(5), e64053. Public Library of Science 10.1371/journal.pone.0064053

Dufour, Jean-François; Bargellini, I.; De Maria, N.; De Simone, P.; Goulis, I.; Marinho, R. T. (2013). Intermediate hepatocellular carcinoma: current treatments and future perspectives. Annals of oncology, 24(Suppl. 2), ii24-ii29. Oxford University Press 10.1093/annonc/mdt054

Lange, Christian M.; Bibert, Stéphanie; Dufour, Jean-François; Cellerai, Cristina; Cerny, Andreas; Heim, Markus H.; Kaiser, Laurent; Malinverni, Raffaele; Müllhaupt, Beat; Negro, Francesco; Semela, David; Moradpour, Darius; Kutalik, Zoltán; Bochud, Pierre-Yves (2013). Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma. Journal of hepatology, 59(3), pp. 504-509. Elsevier 10.1016/j.jhep.2013.04.032

Thattil, Raphael; Dufour, Jean-François (2013). Hepatocellular carcinoma in a non-cirrhotic patient with Wilson's disease. World journal of gastroenterology, 19(13), pp. 2110-2113. WJG Press 10.3748/wjg.v19.i13.2110

Dufour, Jean-François (2013). Modern Hepatomancy. Gastroenterology, 144(5), pp. 876-878. Elsevier 10.1053/j.gastro.2013.03.015

Majumder, Syamantak; Piguet, Anne Christine; Dufour, Jean-François; Chatterjee, Suvro (2013). Study of the cellular mechanism of Sunitinib mediated inactivation of activated hepatic stellate cells and its implications in angiogenesis. European journal of pharmacology, 705(1-3), pp. 86-95. Elsevier 10.1016/j.ejphar.2013.02.026

Dufour, Jean-François (2013). C-reactive protein, a prognostic marker in hepatocellular carcinoma. Hepatology, 57(6), pp. 2103-2105. Wiley Interscience 10.1002/hep.26250

Martin, Juliette; Maurhofer, Olivier; Bellance, Nadège; Benard, Giovanni; Graber, Franziska; Hahn, Dagmar Karen; Galinier, Anne; Hora, Caroline; Gupta, Anirudh; Ferrand, Gisèle; Hoppeler, Hans; Rossignol, Rodrigue; Dufour, Jean-François; St-Pierre, Marie V (2012). Disruption of the histidine triad nucleotide-binding hint2 gene in mice affects glycemic control and mitochondrial function. Hepatology, 57(5), pp. 2037-2048. Hoboken, N.J.: Wiley Interscience 10.1002/hep.26060

Lange, Christian M; Bibert, Stephanie; Kutalik, Zoltan; Burgisser, Philippe; Cerny, Andreas; Dufour, Jean-François; Geier, Andreas; Gerlach, Tilman J; Heim, Markus H; Malinverni, Raffaele; Negro, Francesco; Regenass, Stephan; Badenhoop, Klaus; Bojunga, Jörg; Sarrazin, Christoph; Zeuzem, Stefan; Müller, Tobias; Berg, Thomas; Bochud, Pierre-Yves; Moradpour, Darius; ... (2012). A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C. PLoS ONE, 7(7), e40159. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0040159

Sieghart, Wolfgang; Pinter, Matthias; Dauser, Bernhard; Rohr-Udilova, Natalya; Piguet, Anne-Christine; Prager, Gerald; Hayden, Hubert; Dienes, Hans-Peter; Dufour, Jean-François; Peck-Radosavljevic, Markus (2012). Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma. Journal of hepatology, 57(3), pp. 592-9. Amsterdam: Elsevier 10.1016/j.jhep.2012.04.034

Dufour, Jean-François (2012). Anti-angiogenic therapy for HCC. Minerva medica, 58(1), pp. 81-6. Torino: Minerva Medica

Yao, Francis Y; Breitenstein, Stefan; Broelsch, Christoph E; Dufour, Jean-François; Sherman, Morris (2011). Does a patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma? Liver transplantation, 17 Suppl 2, S109-S116. Hoboken, N.J.: Wiley 10.1002/lt.22335

Hora, Caroline; Romanque, Pamela; Dufour, Jean-François (2011). Effect of sorafenib on murine liver regeneration. Hepatology, 53(2), pp. 577-86. Hoboken, N.J.: Wiley Interscience 10.1002/hep.24037

Van der Meer, AJ; Veldt, BJ; Feld, JJ; Wedemeyer, H; Dufour, Jean-François; Lammert, F; Duarte-Rojo, A; Heathcote, EJ; Manns, MP; Kuske, L; Zeuzem, S; Hofmann, WP; de Knegt, RJ; Hansen, BE; Janssen, HL (2011). Sustained Virological Response Improves Overall Survival in Chronic Hepatitis C Patients with Advanced Fibrosis. Hepatology, 54(1), 441A-441A. Hoboken, N.J.: Wiley Interscience

Van der Meer, AJ; Veldt, BJ; Feld, JJ; Wedemeyer, H; Dufour, Jean-François; Lammert, F; Duarte-Rojo, A; Heathcote, EJ; Manns, MP; Kuske, L; Zeuzem, S; Hofmann, WP; de Knegt, RJ; Hansen, BE; Janssen, HL (2011). Improved Platelet Count and Smaller Spleen Size Long After Sustained Virological Response in Chronic Hepatitis C Patients With Advance Fibrosis. Hepatology, 54(1), 820A-820A. Hoboken, N.J.: Wiley Interscience

Frei, P; Leucht, AK; Held, U; Kofmehl, R; Schmitt, J; Rau, M; Gerlach, T; Negro, F; Heim, MH; Moradpour, D; Cerny, A; Dufour, Jean-François; Mullhaupt, B; Geier, A (2011). Age Above 60 Years Is Not a Negative Predictive Factor For Combined Antiviral Therapy With Pegylated Interferon Alpha and Ribavirin in Hepatitis C Patients. Hepatology, 54(1), 826A-826A. Hoboken, N.J.: Wiley Interscience

Lange, CM; Bibert, S; Kutalik, Z; Morikawa, K; Cerny, A; Dufour, Jean-François; Gerlach, TJ; Heim, MH; Malinverni, R; Muellhaupt, B; Negro, F; Badenhoop, K; Sarrazin, C; Berg, T; Gouttenoire, J; Bochud, PY; Moradpour, D (2011). Swiss Hepatitis C Cohort Study. A Large Scale Genetic Validation Study Coupled With In-Vitro Analysis Reveal a Role of Vitamin D-Signaling in the Pathogenesis and Treatment of Chronic Hepatitis C. Hepatology, 54(1), p. 537. Hoboken, N.J.: Wiley Interscience 10.1016/S0168-8278(11)61359-7

Bochud, PY; Bibert, S; Kutalik, Z; Patin, E; Guergnon, J; Nalpas, B; Goossens, N; Kuske, L; Müllhaup, B; Gerlach, T; Heim, MH; Moradpour, D; Cerny, A; Malinverni, R; Regenass, S; Dollenmaier, G; Hirsch, H; Martinetti, G; Gorgiewski, M; Boulière, M; ... (2011). Swiss Hepatitis C Cohort Study Grp. IL28B Polymorphisms Linked to Poor Response To Treatment are Associated with Low Necroinflammatory Activity and Slow Fibrosis Progression in HCV Genotype Non-1-Infected patientsBern. Hepatology, 54(1), p. 539. Hoboken, N.J.: Wiley Interscience 10.1016/S0168-8278(11)61363-9

Lange, CM; Kutalik, Z; Morikawa, K; Bibert, S; Cerny, A; Dollenmaier, G; Dufour, Jean-François; Gerlach, TJ; Heim, MH; Malinverni, R; Müllhaupt, B; Negro, F; Moradpour, D; Bochud, PY (2011). the Swiss Hepatitis C Cohort Study Group. Hepatology Hoboken, N.J.: Wiley Interscience

Seitz, M; Reichenbach, S; Möller, B; Zwahlen, M; Villiger, PM; Dufour, Jean-François (2010). Hepatoprotective effect of tumour necrosis factor alpha blockade in psoriatic arthritis: a cross-sectional study. Annals of the rheumatic diseases, 69(6), pp. 1148-1150. London: BMJ Publishing Group 10.1136/ard.2009.116194

Balmer, ML; Joneli, J; Schoepfer, A; Stickel, F; Thormann, W; Dufour, Jean-François (2010). Significance of serum adiponection levels in patients with chronic liver disease. Clinical science, 119(10), pp. 431-36. London: Portland 10.1042/CS20100008

Chtiou, H; Mauerhofer, O; Günther, B; Dufour, Jean-François (2010). Macro-AST in an asymptomatic young patient. Annals of hepatology, 9(1), pp. 93-5. México City: Sociedad Mexicana de Hepatologia

Sendensy, A; Dufour, Jean-François (2010). Physiology of Liver Functions. Berlin-Heidelberg: Springer

Dinges, S; Morard, I; Heim, M; Dufour, Jean-François; Müllhaupt, B; Giostra, E; Clavien, P-A; Mentha, G; Negro, F (2009). Pegylated interferon-alpha2a/ribavirin treatment of recurrent hepatitis C after liver transplantation. Transplant infectious disease, 11(1), pp. 33-9. Hoboken, N.J.: Wiley 10.1111/j.1399-3062.2008.00359.x

Prasad, Leonie; Spicher, V M; Negro, F; Rickenbach, M; Dufour, Jean-François (2009). Little evidence that hepatitis C virus leads to a higher risk of mortality in the absence of cirrhosis and excess alcohol intake: the Swiss Hepatitis C Cohort Study. Journal of viral hepatitis, 16(9), pp. 644-649. Oxford: Blackwell Science 10.1111/j.1365-2893.2009.01113.x

Roh, V; Laemmle, A; Von Holzen, U; Stroka, D; Dufour, Jean-François; Hunt, K K; Candinas, D; Vorburger, S A (2008). Dual induction of PKR with E2F-1 and IFN-alpha to enhance gene therapy against hepatocellular carcinoma. Cancer gene therapy, 15(10), pp. 636-44. New York, N.Y.: Nature Publishing Group 10.1038/cgt.2008.34

Helbling, B; Overbeck, K; Gonvers, J-J; Malinverni, R; Dufour, Jean-François; Borovicka, J; Heim, M; Cerny, A; Negro, F; Bucher, S; Rickenbach, M; Renner, E L; Mullhaupt, B (2008). Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infection. Gut, 57(11), pp. 1597-603. London: BMJ Publishing Group 10.1136/gut.2007.142844

Martin, Juliette; Dufour, Jean-François (2008). Tumor suppressor and hepatocellular carcinoma. World journal of gastroenterology, 14(11), pp. 1720-33. Beijing (China): WJG Press 10.3748/wjg.14.1720

Dufour, Jean-François (2007). NASH and thiazolidinediones: not to be taken lightly. Journal of hepatology, 47(4), pp. 451-453. Amsterdam: Elsevier 10.1016/j.jhep.2007.07.012

Banz Wälti, Yara; Rieben, R; Inderbitzin, D; Seiler, C; Schmid, S; Dufour, Jean-François; Smith, R; Nydegger, U; Zimmermann, A; Mohacsi, P; Candinas, Daniel (2007). Immunological preconditioning, including local complement inhibition, in ABO-incompatible auxiliary partial orthotopic liver transplantation as a bridge to definitive grafting in hyperacute liver failure: First report of a successful strategy. Molecular immunology, 44(1-3), pp. 153-154. Amsterdam: Elsevier 10.1016/j.molimm.2006.07.020

Piguet, A; Ledermann, C; Zimmermann, A; Keogh-Stroka, Deborah M.; Dufour, Jean-François (2007). Hypoxia worsens non-alcoholic steatohepatitis. Journal of hepatology, 46(46), S10. Amsterdam: Elsevier 10.1016/S0168-8278(07)61616-X

Dufour, Jean-François; Oneta, CM; Gonvers, JJ; Bihl, F; Cerny, A; Cereda, JM; Zala, JF; Helbling, B; Steuerwald, M; Zimmermann, A; Swiss, Association for the Study of the Liver (2006). Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis. Clinical gastroenterology and hepatology, 4(12), pp. 1537-43. Philadelphia, Pa.: Elsevier 10.1016/j.cgh.2006.09.025

De Gottardi, Andrea; Dufour, Jean-François (2006). [Oesophageal and fundic variceal bleeding]. Therapeutische Umschau, 63(5), pp. 295-9. Bern: Huber

Bissig, Karl-Dimiter; Zimmermann, Arthur; Bernasch, Dirke; Furrer, Hansjakob; Dufour, Jean-François (2003). Herpes simplex virus hepatitis 4 years after liver transplantation. Journal of gastroenterology, 38(10), pp. 1005-1008. Springer 10.1007/s00535-002-1186-0

Provide Feedback